iShares Health Innovation Active ETF (BMED)

Overview

This fund focuses on the health sciences sector, investing a significant portion of its resources into companies engaged in developing products and services aimed at enhancing human health. Operating under normal market conditions, it commits a minimum of 80% of its net assets, plus any borrowings for investment purposes, to equity securities within this group of industries. Its investment approach is characterized by a broad interpretation of health sciences, including not just human healthcare providers and product manufacturers, but also entities involved in aiding the growth or survival of animals and plants. Despite its targeted industry focus, the fund is classified as non-diversified, indicating a potentially concentrated investment strategy in terms of the number of holdings.

Products and Services

• Equity Securities Investment

  Focused primarily on companies engaged in the health sciences industries, the fund invests in equity securities such as stocks. These investments are made in companies that are deemed to play a pivotal role in providing innovative healthcare solutions and services, aiming for growth through advancements in health sciences.

• Human Health Products and Services

  The fund prominently invests in sectors providing health-related products and services aiming to improve human health. This includes pharmaceuticals, medical technologies, hospitals, and healthcare providers that are at the forefront of fighting diseases and improving overall human health and longevity.

• Animal and Plant Health Investments

  Expanding beyond the conventional boundaries of healthcare, the fund also allocates investments to companies focused on the health and survival of animals and plants. This could involve veterinary health providers, biotechnology firms developing treatments or enhancements for non-human species, or agriculture companies working on innovative solutions for plant health and yield improvement.